Pain medicine : the official journal of the American Academy of Pain Medicine
-
Editorial Comment
Preventing pain requires translating biology into social change.
-
Chronic pain is a significant concern for the Veterans Health Administration (VHA), with chronic pain conditions among those most frequently reported by Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF)/Operation New Dawn (OND) veterans. The current study examined VHA electronic medical record data to examine variation in demographics and high prevalence and high impact medical and mental health conditions in order to characterize the differences between patients with persistent pain and no pain. ⋯ The operational definition of chronic pain used in this study may have research implications for examining predictors of incident and chronic pain. These data have important clinical implications in that addressing comorbid conditions of persistent pain may improve adaptive coping and functioning in these patients.
-
The field of pain-related research has gained more attention as the prevalence of chronic pain increased over the years. The objective of this research was to identify highly cited papers, as well as contributors, to pain-related research. ⋯ An indicator like the MCI can provide a proxy for the contributions made by an individual or institution. It reflects the independent research ability and leadership. In future evaluations of institution or individual performances, the MCI should be included, together with the number of total papers, to provide a better profile of research performance.
-
The aim of this study was to investigate pain patterns and the distribution of myofascial trigger points (MTPs) in whiplash-associated disorders (WADs II and III) as compared with mechanical neck pain (MNP). ⋯ Active MTPs are more prominent in WAD than MNP and related to current pain intensity and size of the spontaneous pain distribution in whiplash patients. This may underlie a lower degree of sensitization in MNP than in WAD.
-
Letter Case Reports
Off-label, low-dose naltrexone for refractory chronic low back pain.